Extendicare (TSE:EXE) Issues Quarterly Earnings Results

Extendicare (TSE:EXE) posted its quarterly earnings results on Thursday. The company reported C$0.32 earnings per share (EPS) for the quarter, FiscalAI reports. Extendicare had a net margin of 6.99% and a return on equity of 45.35%. The firm had revenue of C$611.04 million for the quarter.

Extendicare Stock Down 2.1%

Shares of EXE opened at C$34.19 on Friday. The company has a current ratio of 1.44, a quick ratio of 0.98 and a debt-to-equity ratio of 82.55. Extendicare has a 12 month low of C$12.37 and a 12 month high of C$39.14. The firm’s 50 day moving average is C$35.24 and its 200-day moving average is C$30.18. The stock has a market capitalization of C$3.24 billion, a PE ratio of 25.16 and a beta of 1.59.

Extendicare Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Monday, August 17th. Stockholders of record on Monday, August 17th will be issued a dividend of $0.0441 per share. The ex-dividend date of this dividend is Friday, July 31st. This represents a c) annualized dividend and a dividend yield of 1.5%. Extendicare’s dividend payout ratio (DPR) is currently 37.24%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. BMO Capital Markets upped their target price on shares of Extendicare from C$30.00 to C$38.00 in a report on Wednesday, May 13th. Desjardins set a C$34.50 price objective on Extendicare and gave the company a “buy” rating in a research note on Wednesday, April 22nd. Canaccord Genuity Group raised Extendicare to a “strong-buy” rating in a research report on Monday, May 11th. National Bank Financial boosted their target price on Extendicare from C$34.00 to C$40.00 and gave the stock an “outperform” rating in a report on Wednesday, May 27th. Finally, TD lifted their price objective on shares of Extendicare from C$32.00 to C$39.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Two research analysts have rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of C$32.56.

About Extendicare

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.